Total Funding
32
45
Total FundingSecondary Market raised
Growth Score 32 in past quarter
-6 pts
Heat Score 45 in past quarter
-45 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
63851
Arzneimittelwerk Warngau develops and markets drug delivery systems.
- Wilfried Fischer: Founder
- Friedrich Tegel: Managing director
About the Company
Arzneimittelwerk Warngau develops and markets drug delivery systems. Its portfolio includes active ingredient/biodegradable implants and transdermal systems in the areas of oncology, pain therapy, and neurology. It focuses on transdermal passive and microchip controlled patches, as well as subcutaneous biodegradable implants.
Wilfried
Fischer founded Arzneimittelwerk Warngau in 2008. It has its headquarters in Warngau in Germany.

